|
combining treatments of more than one ERBB receptor
I attended a lecture given a representative of the research department of Genentech and they reported that the combinations of Tarceva/Iressa and Herceptin in clinical trials so far had not shown the synergy they had hoped for(and expected due to the preclinical results). Hopes are higher for the Lapatinib-Herceptin combination. The best article on the matter I have found so far is the following. Please let me know if the link doesn't work (I am a novice at this)
mct.aacrjournals.org/cgi/reprint/3/10/1335
|